Imagion Biosystems: Edison Open House Healthcare 2022

Imagion Biosystems: Edison Open House Healthcare 2022

Imagion Biosystems Limited manufactures and supplies medical equipment. The Company offers a bio-imaging detection technology that uses disease specific targeting nanoparticles and highly sensitive detectors to locate tumors and other diseased cells by their molecular signature.

• Tell us about MagSense and its advantages.
• Can this process be used with existing magnetic resonance imaging (MRI) machines?
• Do you see MagSense being used as a screening or a diagnostic tool?
• Do you believe the use of this product could extend beyond breast and prostate cancer?
• Are there potential cost-saving opportunities?
• What is your market strategy?
• Is your product affected by the global shortage of radiologists and other professionals required to read traditional MRI images?
• Which milestones should investors focus on in the coming year?


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free